Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Novo Nordisk A/S (NVO)

-NYSE
44.96 Down 0.29(0.64%) 4:03PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2008
Total Revenue 13,788,000   11,588,000   8,632,294  
Cost of Revenue2,379,000  2,199,000  1,915,656  
Gross Profit 11,408,000   9,389,000   6,716,638  
Operating Expenses
Research Development1,926,000  1,682,000  1,427,125  
Selling General and Administrative4,274,000  3,800,000  2,944,830  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 5,208,000   3,908,000   2,344,684  
Income from Continuing Operations
Total Other Income/Expenses Net22,000  90,000  131,134  
Earnings Before Interest And Taxes5,230,000  3,997,000  2,452,320  
Interest Expense316,000  168,000  46,617  
Income Before Tax4,914,000  3,829,000  2,405,703  
Income Tax Expense1,127,000  843,000  577,975  
Minority Interest -   -   -  
Net Income From Continuing Ops3,787,000  2,986,000  1,827,728  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 3,787,000   2,986,000   1,827,728  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 3,787,000   2,986,000   1,827,728  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.